These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
59 related articles for article (PubMed ID: 25951020)
1. Clinical significance of cervical smears with atypical squamous cells of undetermined significance designated "favor reactive" or "favor preneoplastic". Yang M; Zachariah S J Low Genit Tract Dis; 1997 Jul; 1(3):148-50. PubMed ID: 25951020 [TBL] [Abstract][Full Text] [Related]
2. Reducing or eliminating use of the category of atypical squamous cells of undetermined significance decreases the diagnostic accuracy of the Papanicolaou smear. Pitman MB; Cibas ES; Powers CN; Renshaw AA; Frable WJ Cancer; 2002 Jun; 96(3):128-34. PubMed ID: 12115299 [TBL] [Abstract][Full Text] [Related]
3. Should the cytologic diagnosis of "atypical squamous cells of undetermined significance" be qualified? An assessment including comparison between conventional and liquid-based technologies. Anton RC; Ramzy I; Schwartz MR; Younes P; Chakraborty S; Mody DR Cancer; 2001 Apr; 93(2):93-9. PubMed ID: 11309773 [TBL] [Abstract][Full Text] [Related]
4. Situation analysis of atypical squamous cells of undetermined significance smears in Songklanagarind Hospital. Chichareon SB; Tocharoenvanich ST J Obstet Gynaecol Res; 2002 Oct; 28(5):269-73. PubMed ID: 12428697 [TBL] [Abstract][Full Text] [Related]
5. Atypical squamous cells of undetermined significance in a high-risk population. Takezawa K; Bennett BB; Wilkinson EJ; Hardt NS; Drew PA J Low Genit Tract Dis; 1997 Oct; 1(4):210-3. PubMed ID: 25951205 [TBL] [Abstract][Full Text] [Related]
6. Significance of a diagnosis of atypical squamous cells of undetermined significance for Papanicolaou smears in perimenopausal and postmenopausal women. Keating JT; Wang HH Cancer; 2001 Apr; 93(2):100-5. PubMed ID: 11309774 [TBL] [Abstract][Full Text] [Related]
8. Atypical squamous cells of undetermined significance: a comparative review of original and automated rescreen diagnosis of cervicovaginal smears with long term follow-up. Stastny JF; Remmers RE; London WB; Pedigo MA; Cahill LA; Ryan M; Frable WJ Cancer; 1997 Dec; 81(6):348-53. PubMed ID: 9438460 [TBL] [Abstract][Full Text] [Related]
9. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance. Howell LP; Davis RL Diagn Cytopathol; 1996 Feb; 14(1):20-4. PubMed ID: 8834072 [TBL] [Abstract][Full Text] [Related]
11. Clinical Significance of a cervical cytologic diagnosis of atypical squamous cells of undetermined significance. Favoring a reactive process or low grade squamous intraepithelial lesion. Gonzalez D; Hernandez E; Anderson L; Heller P; Atkinson BF J Reprod Med; 1996 Oct; 41(10):719-23. PubMed ID: 9026557 [TBL] [Abstract][Full Text] [Related]
12. Colposcopic evaluation after a repeat atypical squamous cells of undetermined significance (ASCUS) smear. Gerber S; De Grandi P; Petignat P; Mihaescu A; Delaloye JF Int J Gynaecol Obstet; 2001 Dec; 75(3):251-5. PubMed ID: 11728485 [TBL] [Abstract][Full Text] [Related]
13. Atypical squamous cells of undetermined significance in women over 55. Comparison with the general population and implications for management. Rader AE; Rose PG; Rodriguez M; Mansbacher S; Pitlik D; Abdul-Karim FW Acta Cytol; 1999; 43(3):357-62. PubMed ID: 10349362 [TBL] [Abstract][Full Text] [Related]
14. Is it possible to define a better ASCUS class in cervicovaginal screening? A review of 187 cases. Guerrini L; Sama D; Visani M; Cotignoli T; Sintoni C; Maioli P; Lanzanova G; Schincaglia P Acta Cytol; 2001; 45(4):532-6. PubMed ID: 11480714 [TBL] [Abstract][Full Text] [Related]
15. Atypical squamous cells of undetermined significance (ASCUS): clinical-cytological significance. Lambert B; Boivin Y; Lepage Y Int J Gynecol Cancer; 1999 Jul; 9(4):329-332. PubMed ID: 11240788 [TBL] [Abstract][Full Text] [Related]
16. Impact of the more restrictive definition of atypical squamous cells introduced by the 2001 Bethesda System on the sensitivity and specificity of the Papanicolaou test: a 5-year follow-up study of Papanicolaou tests originally interpreted as ASCUS, reclassified according to Bethesda 2001 criteria. Thrall MJ; Pambuccian SE; Stelow EB; McKeon DM; Miller L; Savik K; Gulbahce HE Cancer; 2008 Jun; 114(3):171-9. PubMed ID: 18454461 [TBL] [Abstract][Full Text] [Related]
17. Eliminating the diagnosis atypical squamous cells of undetermined significance: impact on the accuracy of the Papanicolaou test. Sodhani P; Gupta S; Singh V; Sehgal A; Mitra AB Acta Cytol; 2004; 48(6):783-7. PubMed ID: 15581162 [TBL] [Abstract][Full Text] [Related]
18. Assessment of cytologic follow-up as the recommended management for patients with atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Alanen KW; Elit LM; Molinaro PA; McLachlin CM Cancer; 1998 Feb; 84(1):5-10. PubMed ID: 9500646 [TBL] [Abstract][Full Text] [Related]
19. Reporting of atypical squamous cells of undetermined significance on cervical smears: is it significant? Selvaggi SM; Haefner HK Diagn Cytopathol; 1995 Nov; 13(4):352-6. PubMed ID: 8599925 [TBL] [Abstract][Full Text] [Related]
20. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia. Liao SY; Stanbridge EJ Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]